Chemoinformaics analysis of 6alpha-Acetoxy-16-oxoazadirone
| Molecular Weight | 508.611 | nRot | 3 |
| Heavy Atom Molecular Weight | 472.323 | nRig | 29 |
| Exact Molecular Weight | 508.246 | nRing | 5 |
| Solubility: LogS | -4.615 | nHRing | 1 |
| Solubility: LogP | 3.063 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 5 |
| nHA | 7 | APOL | 79.7186 |
| nHD | 0 | BPOL | 44.7955 |
| QED | 0.532 |
| Synth | 5.163 |
| Natural Product Likeliness | 3.16 |
| NR-PPAR-gamma | 0.204 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.001 |
| HIA | 0.012 |
| CACO-2 | -5.236 |
| MDCK | 0.0000377 |
| BBB | 0.118 |
| PPB | 0.866178 |
| VDSS | 2.136 |
| FU | 0.143955 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.094 |
| CYP2c19-inh | 0.134 |
| CYP2c19-sub | 0.667 |
| CYP2c9-inh | 0.43 |
| CYP2c9-sub | 0.03 |
| CYP2d6-inh | 0.289 |
| CYP2d6-sub | 0.036 |
| CYP3a4-inh | 0.883 |
| CYP3a4-sub | 0.783 |
| CL | 3.354 |
| T12 | 0.431 |
| hERG | 0.317 |
| Ames | 0.007 |
| ROA | 0.954 |
| SkinSen | 0.229 |
| Carcinogencity | 0.123 |
| EI | 0.01 |
| Respiratory | 0.98 |
| NR-Aromatase | 0.446 |
| Antiviral | Yes |
| Prediction | 0.831586 |